[1]邓顺顺,平军娇,章 杰,等.APOE基因多态性与精神分裂症的相关性研究[J].医学信息,2023,36(06):110-113.[doi:10.3969/j.issn.1006-1959.2023.06.024]
　DENG Shun-shun,PING Jun-jiao,ZHANG Jie,et al.Study on the Correlation Between APOE Gene Polymorphism and Schizophrenia[J].Journal of Medical Information,2023,36(06):110-113.[doi:10.3969/j.issn.1006-1959.2023.06.024]
点击复制

APOE基因多态性与精神分裂症的相关性研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年06期
页码:
110-113
栏目:
论著
出版日期:
2023-03-15

文章信息/Info

Title:
Study on the Correlation Between APOE Gene Polymorphism and Schizophrenia
文章编号:
1006-1959（2023）06-0110-04
作者:
邓顺顺; 平军娇; 章 杰; 等
（中山市第三人民医院检验科1，精神疾病遗传学联合实验室2，精神科3，广东 中山 528400）
Author(s):
DENG Shun-shun; PING Jun-jiao; ZHANG Jie; et al.
(Department of Laboratory1,the Joint Laboratory of Psychiatric Genetic Research2,Department of psychiatry3,Zhongshan Third People’s Hospital,Zhongshan 528400,Guangdong,China)
关键词:
精神分裂症; 载脂蛋白E基因; 基因多态性
Keywords:
Schizophrenia; Apolipoprotein E gene; Gene polymorphism
分类号:
R749.3
DOI:
10.3969/j.issn.1006-1959.2023.06.024
文献标志码:
A
摘要:
目的 研究精神分裂症患者载脂蛋白E基因（APOE）多态性的分布情况并探究其多态性对精神分裂症的影响。方法 选取中山市第三人民医院2019年7月-2020年7月收治的123例精神分裂症患者作为试验组，同期52例正常体检成年人为对照组，检测所有受检者的APOE基因型，比较两组受检者APOE基因6种基因型和3种表现型的分布情况并进行研究。结果 两组APOE基因型和表现型分别比较，差异无统计学意义（P＞0.05）；两组不同APOE基因型和表现型的分布比较，差异有统计学意义（P＜0.05）；试验组APOE基因型多态性分布情况为ε2/ε3型7例（5.69%）、ε3/ε3型92例（74.80%）、ε2/ε4型3例（2.44%）、ε3/ε4型21例（17.07%）、ε2/ε2和ε4/ε4型均为0例；表现型：E2型7例（5.69%）、E3型95例（77.24%）、E4型21例（17.07%）；ApoE基因型及表现型在不同性别患者间分布比较，差异无统计学意义（P＞0.05）。结论 APOE基因多态性不是精神分裂症的特定危险因素，其多态性分布与患者性别无关。
Abstract:
Objective To study the distribution of apolipoprotein E gene (APOE) polymorphism in patients with schizophrenia and to explore the effect of its polymorphism on schizophrenia.Methods A total of 123 patients with schizophrenia admitted to the Zhongshan Third People’s Hospital from July 2019 to July 2020 were selected as the experimental group, and 52 healthy adults were selected as the control group during the same period. The APOE genotypes of all subjects were detected, and the distribution of 6 genotypes and 3 phenotypes of APOE gene were compared between the two groups.Results There was no significant difference in ApoE genotype and phenotype between the experimental group and the control group (P＞0.05). There were significant differences in the distribution of different APOE genotypes and phenotypes between the two groups (P<0.05). The distribution of APOE genotype polymorphism in the experimental group was 7 cases (5.69%) of ε2/ε3, 92 cases (74.80%) of ε3/ε3, 3 cases (2.44%) of ε2/ε4, 21 cases (17.07%) of ε3/ε4, 0 case of ε2/ε2 and ε4/ε4; there were 7 cases (5.69%) of E2 type, 95 cases (77.24%) of E3 type and 21 cases (17.07%) of E4 type. There was no significant difference in the distribution of ApoE genotypes and phenotypes between patients of different genders (P＞0.05).Conclusion APOE gene polymorphism is not a specific risk factor for schizophrenia, and its polymorphism distribution is not related to gender.

参考文献/References:

[1]Vancampfort D,Stubbs B,Mitchell AJ,et al.Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis[J].World Psychiatry,2015,14(3):339-347.[2]张媛,侯丽,杨帆,等.APOE基因rs429358和rs7412位点基因多态性与喀什地区维吾尔族人群尿道结石的关系研究[J].国际检验医学杂志,2020,41(12):1453-1456.[3]王瑾,陈韬,刘连,等.ApoE和SLCO1B1基因多态性与冠心病的相关性[J].心脏杂志,2018,30(2):150-153.[4]曾金山.APOE基因表型与冠脉血管病变严重程度相关性研究[D].广州:南方医科大学,2020.[5]颜婉莉.APOE基因多态性与糖、脂及血清尿酸代谢的关联性分析[D].福州:福建医科大学,2018.[6]胡耀,谭昀,桂绍涛,等.高血脂病人载脂蛋白E基因多态性与心肌梗死相关性[J].安徽医药,2020,24(9):1753-1756.[7]Hallman DM,Boerwinkle E,Saha N,et al.The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations[J].Am J Hum Genet,1991,49(2):338-349.[8]喻晓倩,蒋兴亮,方莉,等.拟行PCI术冠心病患者CYP2C19、ApoE基因多态性分布研究[J].中国实验诊断学,2021,25(7):1057-1061.[9]González-Castro TB,Tovilla-Zárate CA,Hernández-Díaz Y,et al.No association between ApoE and schizophrenia: Evidence of systematic review and updated meta-analysis[J].Schizophr Res,2015,169(1-3):355-368.[10]de Vrij FM,Bouwkamp CG,Gunhanlar N,et al.Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia[J].Mol Psychiatry,2019,24(5):757-771.[11]黄正元.APOE、GCH1、KCNJ15基因多态性与精神分裂症认知功能障碍的关联研究[D].昆明:昆明医科大学,2021.[12]Jin L,An Z,Xu B,et al.The association between rs12807809 polymorphism in neurogranin gene and risk of schizophrenia: A meta-analysis[J].Medicine (Baltimore),2019,98(51):e18518.[13]谷愉愉,王丹,龚晨,等.ApoE基因多态性与轻度认知障碍的相关性研究[J].标记免疫分析与临床,2021,28(1):5-10.[14]夏晓伟,孟召然,吴秀华,等.APOE基因多态性与精神分裂症及患者认知功能的关联性研究[J].新医学,2020,51(9):672-676.[15]袁三贵,羊江山,周建鑫,等.载脂蛋白E基因多态性与面肌痉挛发病率的相关性研究[J].重庆医科大学学报,2021,46(5):550-553.[16]Harrington CR,Roth M,Xuereb JH,et al.Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia[J].Neurosci Lett,1995,202(1-2):101-104.[17]Lee MK,Park AJ,Nam BY,et al.Apolipoprotein E genotype in Korean schizophrenic patients[J].J Korean Med Sci,2001,16(6):781-783.[18]Chen JY,Hong CJ,Chiu HJ,et al.Apolipoprotein E genotype and schizophrenia[J].Neuropsychobiology,1999,39(3):141-143.[19]魏洪明,李霞.APOE基因多态性与健康成人认知功能的关系[J].精神医学杂志,2019,32(4):299-302.[20]Chee KY,Salina AA.A review of schizophrenia research in malaysia[J].Med J Malaysia,2014,69 Suppl A:46-54.[21]Chen J,Cao F,Liu L,et al.Genetic studies of schizophrenia: an update[J].Neurosci Bull,2015,31(1):87-98.[22]Schürhoff F,Krebs MO,Sz?觟ke A,et al.Apolipoprotein E in schizophrenia: a French association study and meta-analysis[J].Am J Med Genet B Neuropsychiatr Genet,2003,119B(1):18-23.

相似文献/References:

[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
　ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Journal of Medical Information,2018,31(06):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
　ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Journal of Medical Information,2018,31(06):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
　SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Journal of Medical Information,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状 疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
　CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Journal of Medical Information,2018,31(06):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[5]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
　SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Journal of Medical Information,2022,35(06):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[6]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
　SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Journal of Medical Information,2018,31(06):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[7]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
　WU Jin-li.Clinical Application of Aripiprazole[J].Journal of Medical Information,2018,31(06):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[8]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
　SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Journal of Medical Information,2018,31(06):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[9]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
　LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Journal of Medical Information,2018,31(06):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[10]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
　HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Journal of Medical Information,2018,31(06):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]

更新日期/Last Update: 1900-01-01